DrugPatentWatch Database Preview
TESTOSTERONE PROPIONATE Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
When do Testosterone Propionate patents expire, and what generic alternatives are available?
Testosterone Propionate is a drug marketed by Bel Mar, Elkins Sinn, Lilly, and Watson Labs. and is included in eight NDAs.
The generic ingredient in TESTOSTERONE PROPIONATE is testosterone propionate. There are sixty-nine drug master file entries for this compound. Additional details are available on the testosterone propionate profile page.
Summary for TESTOSTERONE PROPIONATE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 8 |
Bulk Api Vendors: | 61 |
Patent Applications: | 3,449 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TESTOSTERONE PROPIONATE at DailyMed |

Synonyms for TESTOSTERONE PROPIONATE
.DELTA.4-androstene-17.beta.-propionate-3-one |
(17beta)-3-oxoandrost-4-en-17-yl propanoate |
(17beta)-3-oxoandrost-4-en-17-yl propionate |
(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl propionate |
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate |
003T653 |
1050678-75-5 |
17-(1-Oxopropoxy)androst-4-en-3-one, (17.beta.)- |
17-propionyl-17beta-hydroxyandrost-4-en-3-one |
17.beta.-(Propionyloxy)androst-4-en-3-one |
17.beta.-hydroxyandrost-4-en-3-one, propionate |
17|A-Hydroxy-4-androsten-3-one 17-propionate |
17|A-Propionyloxy-4-androsten-3-one |
17beta-(Propionyloxy)androst-4-en-3-one |
17beta-Hydroxy-4-androsten-3-one 17-propionate |
17beta-Hydroxyandrost-4-en-3-one propionate |
17beta-Hydroxyandrost-4-en-3-one-17beta-propionate |
3-Oxoandrost-4-en-17-yl propionate, (17.beta.)- |
4-Androsten-17|A-ol-3-one 17-propionate |
57-85-2 |
AB2000654 |
AC-12172 |
AC1L1LKI |
AC1Q6OD1 |
Agovirin |
AI3-26378 |
AKOS005622513 |
AKOS015842719 |
AN-41735 |
Androgen |
Androlon |
Androlon, Androtest P, Androteston, Aquaviron, Bio-testiculina, Enarmon, Hormoteston, NRB 03689, NSC |
Andronate |
Androst-4-en-3-one, 17-(1-oxopropoxy)-, (17.beta.)- |
Androst-4-en-3-one, 17-(1-oxopropoxy)-, (17b)- |
Androst-4-en-3-one, 17-(1-oxopropoxy)-, (17beta)- |
Androst-4-en-3-one, 17-(1-oxopropoxy)-(17.beta.)- |
Androst-4-en-3-one, 17.beta.-hydroxy-, propionate |
Androst-4-en-3-one, 17beta-hydroxy-, propionate |
Androsteston |
Androtest P |
Androteston |
Andrusol-P |
Aquaviron |
BBL029912 |
BCP0726000215 |
BCP23359 |
BDBM50215709 |
Bio-testiculina |
BPBio1_000356 |
BRD-K90553655-001-03-6 |
BSPBio_000322 |
C-20456 |
C08158 |
CAS-57-85-2 |
CC-34822 |
CCG-220401 |
CCRIS 575 |
CHEBI:9466 |
CHEMBL1170 |
CS-4905 |
D00959 |
DB01420 |
delta(sup 4)-Androstene-17-beta-propionate-3-one |
DSSTox_CID_16515 |
DSSTox_GSID_36515 |
DSSTox_RID_79286 |
DTXSID9036515 |
EINECS 200-351-1 |
Enarmon |
Enarmon-oil |
GTPL7100 |
HMS1569A04 |
HMS2096A04 |
HMS2272K06 |
HMS3713A04 |
Homandren (amps) |
Hormoteston |
HY-B1269 |
LMST02020076 |
LS-148823 |
Masenate |
MCULE-8627319345 |
MLS002153796 |
Nasdol |
NCGC00016254-01 |
NCGC00179602-01 |
NCGC00179602-03 |
NCGC00255481-01 |
Neo-Hombreol |
NRB 03689 |
NSC 9166 |
NSC-9166 |
NSC9166 |
Okasa-Mascul |
Orchiol |
Orchisterone |
Orchistin |
Oreton propionate |
Pantestin |
PDMMFKSKQVNJMI-BLQWBTBKSA-N |
Prestwick_432 |
Prestwick0_000401 |
Prestwick1_000401 |
Prestwick2_000401 |
Prestwick3_000401 |
Propiokan |
Propionic acid (8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester |
Propionic acid 10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester |
Propionic acid 10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester(Testosterone Propionate) |
Recthormone testosterone |
SC-16231 |
SCHEMBL4044 |
SMR000058348 |
Solvotest |
SPBio_002261 |
Sterandryl |
STK801834 |
Synandrol |
Synerone |
Telipex |
Testaform |
Testex |
Testex (TN) |
Testodet |
Testodrin |
Testogen |
Testolets |
Testonique |
Testormol |
Testosid |
Testosteron propionate |
Testosterone (propionate) |
Testosterone propionate (Agovirin) |
Testosterone propionate (JP17/USP) |
Testosterone propionate [Androgenic (anabolic) steroids] |
Testosterone propionate [USAN:JAN] |
Testosterone propionate [USP:JAN] |
Testosterone Propionate 1.0 mg/ml in Acetonitrile |
Testosterone propionate for system suitability, European Pharmacopoeia (EP) Reference Standard |
Testosterone propionate, British Pharmacopoeia (BP) Reference Standard |
Testosterone propionate, European Pharmacopoeia (EP) Reference Standard |
Testosterone propionate, solid |
Testosterone propionate, tested according to Ph.Eur. |
Testosterone propionate, United States Pharmacopeia (USP) Reference Standard |
Testosterone-17-beta-propionate |
Testosterone-17-propionate |
Testosterone-17.beta.-propionate |
Testosterone-17.beta.propionate |
Testosterone-17beta propionate |
Testosterone-17beta-propionate |
Testosterone, propionate |
Testosteroni propionas |
Testoviron (ampule) |
Testoxyl |
Testrex |
Tostrin |
Tox21_110330 |
Tox21_110330_1 |
Tox21_302270 |
TX-012595 |
UNII-WI93Z9138A |
Uniteston |
Vulvan |
W-105436 |
WI93Z9138A |
WLN: L E5 B666 OV MUTJ A E FO52 -B&AEF |
ZB014171 |
ZINC490791 |
US Patents and Regulatory Information for TESTOSTERONE PROPIONATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bel Mar | TESTOSTERONE PROPIONATE | testosterone propionate | INJECTABLE;INJECTION | 080741-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Watson Labs | TESTOSTERONE PROPIONATE | testosterone propionate | INJECTABLE;INJECTION | 085490-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Elkins Sinn | TESTOSTERONE PROPIONATE | testosterone propionate | INJECTABLE;INJECTION | 080276-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Watson Labs | TESTOSTERONE PROPIONATE | testosterone propionate | INJECTABLE;INJECTION | 080188-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |